Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Subjects at Particular Risk of Infection With Human Immunodeficiency Virus (HIV).

NCT03436407 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03436407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03436407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Subjects at Particular Risk of Infection With Human Immunodeficiency Virus (HIV).
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 25, 2017
Completion date
December 31, 2020
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, mental health wellness 1, sexually transmitted diseases